Cite
HARVARD Citation
Desai, R. et al. (2019). Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study. Arthritis & rheumatology. 71 (6), pp. 892-900. [Online].